Shanghai / Hilden / Wuxi / Helsinki / Welfare / Wilmington / Hangzhou / Nagoya / San Diego / Chicago / /
Company
SPSS Inc. / Kubota / Atici AG / Roche pharmaceuticals co. LTD / Stacy AE / Caucasian / Furukawa / Qiagen / Astrazeneca pharmaceutical co. LTD / G/A GG AG / Ford / Cox / Creative Commons / Sequenom / pharmaceutical co. LTD / Google / carried out using SPSS / /
Country
Germany / Japan / United States / China / / /
Event
FDA Phase / /
Facility
Nanjing Medical University / Nanjing Medical University Affiliated Hangzhou Hospital / Hangzhou First People’s Hospital / Virtual Research Institute of Aging / /
IndustryTerm
cancer therapeutics / pharmaceuticals / online submission / /
MedicalCondition
advanced disease / solid tumours / EGFR-mutated non-small cell lung cancer / progression disease / skin rash / EGFR mutation-positive non-small-cell lung cancer / Breast cancer resistance protein / J Cancer / prevalent and fatal malignant neoplasm / small-cell lung cancer / Non-small-cell lung cancer / non-small cell lung cancer / advanced non-small cell lung cancer / diarrhea / Felip E. Metastatic non-small-cell lung cancer / MS / III-N2 non-small-cell lung carcinoma / breast cancer / advanced non-small-cell lung cancer / primary tumors / IV non-small cell lung cancer / tumor / Chinese advanced non-small-cell lung cancer / adenocarcinoma vs others / adenocarcinomas / Cancer / disease / NSCLC / Belani C. Skin rash / molecular cancer / malignant pleural effusions / III non-small-cell lung cancer / lung cancer / Response Evaluation Criteria In Solid Tumors / non-small-cell lung cancer harbouring mutations / BMC Cancer / stable disease / therapy Background Lung cancer / /
MedicalTreatment
Chemotherapy / cancer therapeutics / /
MusicAlbum
Culture / Technology / Sports / Science / /
Organization
Affiliated Hangzhou Hospital / Zhejiang Provincial Natural Science Foundation / Wu Jieping / Hangzhou First People’s Hospital / Nanjing Medical University / Virtual Research Institute of Aging of Nippon Boehringer Ingelheim / CC CA AA / Department of Medical Oncology / Ministry of Education / Ministry of Health / Nanjing Medical University Affiliated Hangzhou Hospital / /
Person
Van De Wetering / Shenglin Ma / Shaoyu Yang / Yuelong Pan / Dadong Chen / Yang C. Epidermal / Ruobing Ma / Molecular / Van Der Straaten / Ann Oncol / Xin Li / / /
Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients